Since these are difficult diseases to treat, research has been quite slow over the last decade or so, but continues to pick up, developing new treatments for patients with these diseases.
Kathleen Weis, CEO
Advertisement
Articles by Kathleen Weis, CEO
Advertisement
Latest Updated Articles
Exciting Advancements for Rare Blood DiseasesPublished: August 21st 2018 | Updated:
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Exousia Pro Orphan Drug Designation in Glioma
2
Sharing Insights Into a Multiple Myeloma Journey
3
How Breast Cancer Treatment Can Impact Menopause and Fertility
4
What to Know About the FDA Approval of Blenrep for Multiple Myeloma
5
